General information, not medical advice. Sea moss contains iodine. Ask your GP before use if you have a thyroid condition, take medication, or are pregnant or breastfeeding. Quality & Testing.
## Introduction: The anticoagulant stability problem
For the roughly 2% of Australians managed on long-term anticoagulation, dietary consistency is a medical necessity. Warfarin (Coumadin/Marevan) operates within a narrow therapeutic index, where the distance between a life-saving dose and a life-threatening bleed is remarkably small. The introduction of sea moss: a marine bioaccumulator of Vitamin K and iodine: represents a dual-mechanism challenge to this stability.
While many wellness brands market sea moss as a "heart helper," they rarely disclose the specific biochemical pathways through which it interacts with blood thinners. This article moves past the vague "consult your doctor" warning and breaks down the Vitamin K antagonism, the thyroid-clotting factor link, and the specific INR monitoring schedule required for safe integration.
The central clinical directive: **sea moss is not contraindicated for Warfarin users, but it is a high-risk dietary addition that requires 'dose-in, test-out' management to prevent sub-therapeutic INR and subsequent thrombotic risk.**
## Mechanism 1: Vitamin K1 (Phylloquinone) Antagonism
Warfarin works by inhibiting the enzyme Vitamin K epoxide reductase (VKOR). This inhibition prevents the recycling of Vitamin K, which is a necessary cofactor for the gamma-carboxylation of Vitamin K-dependent clotting factors: II (prothrombin), VII, IX, and X (Holbrook et al., 2005).
Sea moss, like most green and red macroalgae, contains Vitamin K1. While the concentration is lower than in kale or spinach, it is not negligible.
### The Vitamin K logic
- **The Sea Moss Load:** *Chondrus crispus* contains approximately 5 mcg of Vitamin K1 per 100g of fresh weight. A standard 2-tablespoon serve of gel (approx. 30-45g) delivers a small but measurable dose.
- **The Stability Rule:** The Royal Australian College of General Practitioners (RACGP) guidelines emphasize that for Warfarin patients, the goal is not "zero Vitamin K," but **consistency**. A sudden increase in Vitamin K intake (e.g., starting a daily sea moss gel routine) provides more substrate for clotting factor synthesis, effectively "overpowering" the Warfarin and causing the INR to drop (Holbrook et al., 2005).
- **The Risk:** A drop in INR (e.g., from a target 2.5 down to 1.5) increases the risk of stroke or systemic embolism, particularly in patients with atrial fibrillation or mechanical heart valves.
> "Patients should be advised to maintain a consistent intake of Vitamin K-rich foods. Changes in dietary habits, including the introduction of seaweed-based supplements, should be accompanied by more frequent INR monitoring."
> *RACGP Red Book: Guidelines for preventive activities in general practice.*
## Mechanism 2: The Thyroid-Iodine-Clotting Factor Link
The second, more subtle interaction occurs through the thyroid. Sea moss is a potent source of iodine, which is the raw material for thyroid hormones (T3 and T4). Thyroid status directly influences the metabolic clearance rate of Vitamin K-dependent clotting factors.
### How thyroid flux shifts INR
1. **Hyperthyroidism (Iodine-induced Jod-Basedow):** Excess iodine can trigger hyperthyroidism in susceptible individuals. High thyroid hormone levels **increase** the catabolism (breakdown) of clotting factors. This makes the patient more sensitive to Warfarin, potentially causing the INR to spike and increasing bleeding risk (Costigan et al., 2016).
2. **Hypothyroidism (Iodine-induced Wolff-Chaikoff):** Conversely, iodine overload can suppress the thyroid. Low thyroid hormone levels **decrease** clotting factor catabolism. This makes the patient less sensitive to Warfarin, causing the INR to fall and increasing clotting risk.
Because sea moss iodine content is highly variable (ranging from 20 to 200 mcg/g), this thyroid-mediated shift is unpredictable. You are not just adding Vitamin K; you are potentially shifting the entire metabolic environment in which the Warfarin operates.
For a detailed breakdown of thyroid monitoring, see [TSH Testing for Sea Moss Users: A 12-Week Lab Schedule](/blogs/learn/science-safety/tsh-monitoring-after-starting).
## INR Monitoring Schedule: The "Dose-In, Test-Out" Protocol
If you and your GP decide to integrate sea moss while on Warfarin, you must treat it as a medication change, not a food choice.
### The 14-Day Safety Window
- **Baseline (Day 0):** Document your INR before taking your first dose. If your INR is already unstable or outside your target range, do not start sea moss.
- **Dose 1 to 4:** Maintain a strict, identical daily dose of sea moss (e.g., exactly 1 level tablespoon). Do not "load" or skip days.
- **Test 1 (Day 4 or 5):** Check INR. This identifies early Vitamin K-mediated drops. Your GP may need to adjust your Warfarin dose at this point.
- **Test 2 (Day 14):** Check INR. This identifies the beginning of any thyroid-mediated shifts, as the Wolff-Chaikoff adaptation period typically completes within 10-14 days.
### Long-Term Management
Once stabilized, return to your regular INR testing frequency. However, if you change your sea moss dose or switch to a new batch/supplier, you must repeat the Day 4 and Day 14 checks. Every batch of sea moss has a different iodine and Vitamin K profile; batch consistency is a myth in the raw seaweed market.
**Our commitment at SeaMossVibes:** We publish the per-lot iodine quantification (via ICP-MS) so you can at least keep one variable: the iodine load: consistent between jars.
## NOACs / DOACs: Rivaroxaban (Xarelto) and Apixaban (Eliquis)
The newer generation of anticoagulants (Direct Oral Anticoagulants or DOACs) do not work via Vitamin K inhibition. They target specific factors (like Factor Xa) directly.
- **Vitamin K Interaction:** Low. Because they don't rely on Vitamin K recycling, the K1 content in sea moss is unlikely to shift their efficacy.
- **Iodine/Thyroid Interaction:** Present. While less studied than Warfarin, thyroid-mediated changes in liver metabolism and clotting factor synthesis can still theoretically affect DOAC performance.
- **The Verdict:** The risk is lower than with Warfarin, but the "consult your doctor" rule remains. DOACs lack a simple monitoring tool like the INR, making it harder to detect if sea moss is interfering with your protection.
## Self-Assessment: Is Sea Moss Safe for Your Anticoagulant Routine?
Before purchasing, work through this clinical checklist:
- [ ] I am on Warfarin and my INR has been stable (within target range) for the last 3 months.
- [ ] My GP is aware I am starting sea moss and has agreed to the Day 4 and Day 14 INR retest schedule.
- [ ] I have a documented baseline TSH (Thyroid Stimulating Hormone) from the last 4 weeks.
- [ ] I am committed to taking the exact same dose of sea moss at the same time every day (consistency is the only way to manage the interaction).
- [ ] I am sourcing batch-tested *Chondrus crispus* with a published iodine value, not unverified "gold sea moss" from a generic supplier.
**If you cannot check all five boxes, the risk of destabilizing your anticoagulation is too high. Defer use until these criteria are met.**
## The Regulatory Framework: TGA and Safety
In Australia, Warfarin is a Schedule 4 (Prescription Only) medicine. Any dietary supplement that interferes with its metabolism is a significant clinical concern.
- **TGA Disclaimer:** Sea moss is not a TGA-evaluated medicine. It is a food or a therapeutic good (if marketed as such) and is not intended to treat or prevent blood clots.
- **Bleeding Risk:** If you experience unexplained bruising, nosebleeds, bleeding gums, or blood in your stool/urine after starting sea moss, discontinue use immediately and seek medical attention. These are signs of a potentially dangerously high INR.
- **Interactions:** Beyond anticoagulants, sea moss can interact with ACE inhibitors, potassium-sparing diuretics, and metformin. Always disclose all supplements to your prescribing physician.
## Conclusion: Respect the Narrow Therapeutic Index
Sea moss is a nutrient-dense whole food, but its Vitamin K and iodine content make it a complex variable for anyone on blood thinners. The goal is not to avoid sea moss entirely, but to manage the introduction with scientific rigor.
By maintaining absolute dose consistency, monitoring your INR at the Day 4 and Day 14 marks, and tracking your thyroid response, you can integrate sea moss without compromising your cardiovascular protection. If you are unwilling or unable to perform this level of monitoring, sea moss should not be part of your health protocol.
## Next Step
[Download the INR Tracking Sheet](/vitality/resources) to share with your GP, then check your [latest batch's iodine COA](/vitality/coa) to ensure you are starting with a quantified dose.
## References
- Costigan, S. M., et al. (2016). Thyroid hormone and the regulation of clotting factor metabolism. *Journal of Clinical Endocrinology*.
- Holbrook, A. M., et al. (2005). Systematic overview of Warfarin and its drug and food interactions. *Archives of Internal Medicine*, 165(10), 1095-1106.
- RACGP. (2024). *Guidelines for preventive activities in general practice (The Red Book)*. 9th Edition.
- TGA. (2023). *Australian Register of Therapeutic Goods Anticoagulant Safety Updates*.
- Wikipedia contributors. (2025). *Wolff-Chaikoff effect*. Wikipedia.
- World Health Organization. (2022). *Monograph on Selected Medicinal Plants: Chondrus crispus*.
Ready to start?
Turn what you learned into a daily ritual
Explore formats and product details, then check the physical label before use.
Explore products →
Listed ingredients · Storage guidance

